Drugmakers push to break ground after Trump’s 100% tariff threatnews2025-10-23T13:27:43+00:00October 23rd, 2025|Endpoints News|
Drug launch prices spiked from 2022 to 2024, new ICER report findsnews2025-10-23T12:00:38+00:00October 23rd, 2025|Endpoints News|
Roche in talks with US on drug pricing, sets out pipeline and dealmaking ambitionsnews2025-10-23T10:34:49+00:00October 23rd, 2025|Endpoints News|
Moderna’s CMV vaccine fails Phase 3 study, company to halt most developmentnews2025-10-22T20:05:30+00:00October 22nd, 2025|Endpoints News|
Alkermes to buy Avadel for up to $2.1Bnews2025-10-22T19:27:45+00:00October 22nd, 2025|Endpoints News|
Major pharma companies spent more on lobbying in third quarternews2025-10-22T19:14:28+00:00October 22nd, 2025|Endpoints News|
Arcturus announces mixed results of mRNA cystic fibrosis therapy, Covid-19 vaccine delaynews2025-10-22T18:39:22+00:00October 22nd, 2025|Endpoints News|
Thermo Fisher, Danaher stand to gain from drugmakers’ onshoring effortsnews2025-10-22T17:11:30+00:00October 22nd, 2025|Endpoints News|
Top drugmakers’ jets have descended on DC more than 120 times this yearnews2025-10-22T14:45:41+00:00October 22nd, 2025|Endpoints News|
Ipsen to buy ImCheck for €350M to get ‘superfamily’ of immunotherapiesnews2025-10-22T10:28:46+00:00October 22nd, 2025|Endpoints News|
